Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Tourmaline Bio Inc increased its cash reserves by 1,563.36%, or 132.48m. Cash Flow from Financing totalled 156.72m or -- of revenues. In addition the company used 28.08m for operations while cash from investing totalled 3.84m.
Cash flow per share | -2.41 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 12.52 |
---|---|
Tangible book value per share | 12.52 |
More ▼
Balance sheet in USDView more
Current ratio | 40.33 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼